cardiovascular health
-
New Diabetes Drug Reduces Heart Attack and Stroke Risk
Great news for people with diabetes and kidney disease! A newly FDA-approved drug called Sotagliflozin has been proven to significantly lower the risk of heart attacks and strokes. What is Sotagliflozin? Sotagliflozin is a medication designed to treat type 2 diabetes and kidney disease. What makes it different from other diabetes drugs is its ability…